4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000008
Chief Financial Officer sold 4,086 shares at $12.31 ($50,285)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| WENTWORTH KORY JAMES Chief Financial Officer | 2024-03-06 | Sale 10b5-1 | −4,086 | $12.31 | $50,285 | 74,170 | D |
| Open-market sales · 4,086 sh · avg $12.31 · $50,285 | |||||||
Loading xslF345X05/wk-form4_1709933772.xml…